<DOC>
	<DOC>NCT01020253</DOC>
	<brief_summary>The purpose of this study is to evaluate whether alendronate and alfacalcidol are effective on prosthetic or lumbar spine BMD after total hip arthroplasty.</brief_summary>
	<brief_title>The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)</brief_title>
	<detailed_description />
	<mesh_term>Alfacalcidol</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<criteria>osteoarthritis of the hip patients after total hip arthroplasty diseases related to bone metabolism patients taking drugs which affect bone metabolism</criteria>
	<gender>All</gender>
	<minimum_age>44 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>bisphosphonate, vitamin D3</keyword>
	<keyword>Total Hip arthroplasty</keyword>
</DOC>